These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 12623070

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.
    Schleicher ED, Wagner E, Nerlich AG.
    J Clin Invest; 1997 Feb 01; 99(3):457-68. PubMed ID: 9022079
    [Abstract] [Full Text] [Related]

  • 3. Accumulation of advanced glycation endproducts in the rat nephron: link with circulating AGEs during aging.
    Verbeke P, Perichon M, Borot-Laloi C, Schaeverbeke J, Bakala H.
    J Histochem Cytochem; 1997 Aug 01; 45(8):1059-68. PubMed ID: 9267467
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glycoxidative modification of AA amyloid deposits in renal tissue.
    Uesugi N, Sakata N, Nagai R, Jono T, Horiuchi S, Takebayashi S.
    Nephrol Dial Transplant; 2000 Mar 01; 15(3):355-65. PubMed ID: 10692521
    [Abstract] [Full Text] [Related]

  • 7. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
    Imanaga Y, Sakata N, Takebayashi S, Matsunaga A, Sasaki J, Arakawa K, Nagai R, Horiuchi S, Itabe H, Takano T.
    Atherosclerosis; 2000 Jun 01; 150(2):343-55. PubMed ID: 10856526
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis.
    Motomiya Y, Oyama N, Iwamoto H, Uchimura T, Maruyama I.
    Kidney Int; 1998 Oct 01; 54(4):1357-66. PubMed ID: 9767556
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. N(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress.
    Nerlich AG, Schleicher ED.
    Atherosclerosis; 1999 May 01; 144(1):41-7. PubMed ID: 10381276
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S, Tachikawa T, Tobita K, Aoyama I, Takayama F, Enomoto A, Niwa T.
    Am J Kidney Dis; 2003 Mar 01; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients.
    Vay D, Vidali M, Allochis G, Cusaro C, Rolla R, Mottaran E, Bellomo G, Albano E.
    Diabetologia; 2000 Nov 01; 43(11):1385-8. PubMed ID: 11126407
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.